www.cnbc.com Open in urlscan Pro
104.111.214.166  Public Scan

Submitted URL: http://go.pardot.com/e/710433/-future-of-covid-boosters-html/cyhr8/472333661?h=XBeGPld92GcVlq9oAry9xnfGngHVFWwZMVT-v2...
Effective URL: https://www.cnbc.com/2022/03/21/fda-advisory-committee-to-discuss-future-of-covid-boosters.html
Submission: On March 22 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip Navigation
BREAKING
Stocks rebound Tuesday, Dow gains 150 points led by Nike

FDA advisory committee to discuss future of Covid boosters
 * watchliveSquawk on the Street

Markets
 * Pre-Markets
 * U.S. Markets
 * Europe Markets
 * China Markets
 * Asia Markets
 * World Markets
 * Currencies
 * Cryptocurrency
 * Futures & Commodities
 * Bonds
 * Funds & ETFs

Business
 * Economy
 * Finance
 * Health & Science
 * Media
 * Real Estate
 * Energy
 * Climate
 * Transportation
 * Industrials
 * Retail
 * Wealth
 * Life
 * Small Business

Investing
 * Invest In You
 * Personal Finance
 * Fintech
 * Financial Advisors
 * Trading Nation
 * Options Action
 * ETF Street
 * Buffett Archive
 * Earnings
 * Trader Talk

Tech
 * Cybersecurity
 * Enterprise
 * Internet
 * Media
 * Mobile
 * Social Media
 * CNBC Disruptor 50
 * Tech Guide

Politics
 * White House
 * Policy
 * Defense
 * Congress
 * Equity and Opportunity
 * Europe Politics
 * China Politics
 * Asia Politics
 * World Politics

CNBC TV
 * Live Audio
 * Latest Video
 * Top Video
 * CEO Interviews
 * Europe TV
 * Asia TV
 * CNBC Podcasts
 * Digital Originals

Watchlist
Investing Club
 * Newsletter
 * Morning Meeting
 * Trade Alerts
 * Trust Portfolio

PRO
 * Pro News
 * Pro Live
 * Subscribe
 * Sign In



Menu

 * Make It

 * USA
 * INTL

Search quotes, news & videos
Watchlist
SIGN IN
FDA advisory committee to discuss future of Covid boosters
 * watchliveSquawk on the Street

Markets
Business
Investing
Tech
Politics
CNBC TV
Watchlist
Investing Club
PRO


Menu


Health and Science


FDA ADVISORY COMMITTEE TO DISCUSS FUTURE OF COVID BOOSTERS

Published Mon, Mar 21 202212:26 PM EDTUpdated Mon, Mar 21 20221:08 PM EDT
Spencer Kimball@spencekimball
WATCH LIVE
ShareShare Article via FacebookShare Article via TwitterShare Article via
LinkedInShare Article via Email
Key Points
 * An FDA advisory committee will discuss the timing of Covid-19 boosters for
   the coming months and what factors would make it necessary to update the
   shots to target specific Covid variants.
 * The meeting will take place April 6.
 * The FDA decides which flu vaccine should be used every year based on which
   variant is circulating. Covid-19 vaccines will likely be handled in a similar
   way moving forward.

A nurses fills up syringes for patients as they receive their coronavirus
disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination
clinic in Southfield, Michigan, September 29, 2021.
Emily Elconin | Reuters

A Food and Drug Administration advisory committee will meet next month to
discuss the future of Covid-19 booster shots in the U.S. and whether the
vaccines should be updated to target specific variants.

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet
April 6 to debate the timing of Covid boosters for the coming months as well as
when the shots should be updated to target specific variants. They haven’t
scheduled a specific vote nor are they expected to discuss Pfizer or Moderna’s
recent applications for fourth Covid vaccine doses.



Public health experts and the vaccine makers have said Covid will eventually
become a seasonal virus like the flu, which has higher transmission during the
winter months and then recedes when the weather turns warm again. The CEOs of
Pfizer and Moderna have both said annual vaccinations against Covid will be
necessary similar to the flu, particularly for the elderly and those with
underlying conditions.

Ever year, the FDA advisory committee decides which flu vaccine should be
administered in the U.S. based on what strain is circulating and other factors.
The committee will likely take a similar approach to Covid vaccines moving
forward.

“Now is the time to discuss the need for future boosters as we aim to move
forward safely, with COVID-19 becoming a virus like others such as influenza
that we prepare for, protect against, and treat,” said Dr. Peter Marks, the head
of the FDA’s vaccine safety group.


CNBC HEALTH & SCIENCE

Read CNBC’s latest global coverage of the Covid pandemic:

 * Health experts predict uptick in U.S. Covid cases due to new BA.2 variant
 * China is managing its Covid outbreak one new local crisis at a time
 * Moderna CEO Bancel has sold more than $400 million of company stock during
   pandemic
 * China’s Covid spike: What we know and don’t know about its economic impact
 * Covid pushed almost 5 million in Southeast Asia into extreme poverty in 2021
 * Vaccine maker stocks rise as China battles worst Covid outbreak since 2020


View More

TV
Squawk on the StreetWATCH LIVEWATCH IN THE APP
UP NEXT | TechCheck 11:00 am ETListen
TV
Squawk on the StreetWATCH LIVEWATCH IN THE APP
UP NEXT | TechCheck 11:00 am ETListen

Trending Now

 1. China crash is ‘unprecedented’ given Boeing 737′s stellar safety record,
    says aviation analyst
    
 2. Zelenskyy calls for more pressure on Moscow as Ukraine says 15,000 Russian
    troops have been killed
    
 3. Stocks making the biggest moves in the premarket: Nike, Okta, Alibaba and
    more
    
 4. These charts show how much it costs to charge an EV vs. refueling a gas
    vehicle
    
 5. Porn star Stormy Daniels loses appeal in Trump case, owes former president
    almost $300,000
    




 * Subscribe to CNBC PRO
 * Licensing & Reprints
 * CNBC Councils
 * Supply Chain Values
 * CNBC on Peacock
 * Advertise With Us
 * Join the CNBC Panel
 * Digital Products
 * News Releases
 * Closed Captioning
 * Corrections
 * About CNBC
 * Internships
 * Site Map
 * Manage Cookie Preferences
 * Careers
 * Help
 * Contact

 * 
 * 
 * 
 * 
 * 
 * 
 * 

NEWS TIPS

Got a confidential news tip? We want to hear from you.

Get In Touch

CNBC NEWSLETTERS

Sign up for free newsletters and get more CNBC delivered to your inbox

Sign Up Now

Get this delivered to your inbox, and more info about our products and
services. 

Privacy Policy|Do Not Sell My Personal Information|CA Notice|Terms of Service

© 2022 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global
Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by






COOKIE SETTINGS

We and our partners collect information from your device, such as device
identifiers, IP address, and your browser type to personalize and deliver
content, marketing and advertising—across devices and platforms; for analytics
and measurement, so we can improve our services and develop new ones; to match
and combine offline data with your online activity; and for social features. We
share this information with selected partners with your consent. By clicking
“Allow All”, you consent to our use of these Cookies. Click on the Cookie
categories or the “Detailed purpose descriptions” below to learn more about
these Cookies. We will also use other Cookies that are essential for our site
and Services, including for security and fraud prevention. To learn more about
some of our partners, see the List of IAB Vendors below. Visit our Cookie Notice
and Privacy Policy to learn more.
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These Cookies are required for Service functionality, including security and
fraud prevention, and to enable any purchasing capabilities. You can set your
browser to block these Cookies, but some parts of the site may not function
properly.

Non-IAB Cookies‎

ENSURE SECURITY, PREVENT FRAUD, AND DEBUG

Always Active

Your data can be used to monitor for and prevent fraudulent activity, and ensure
systems and processes work properly and securely.

List of IAB Vendors‎ | Detailed Purpose Descriptions Opens in a new Tab

TECHNICALLY DELIVER ADS OR CONTENT

Always Active

Your device can receive and send information that allows you to see and interact
with ads and content.

List of IAB Vendors‎ | Detailed Purpose Descriptions Opens in a new Tab

STORE AND/OR ACCESS INFORMATION ON A DEVICE

Store and/or access information on a device

Cookies, device identifiers, or other information can be stored or accessed on
your device for the purposes presented to you.

List of IAB Vendors‎ | Detailed Purpose Descriptions Opens in a new Tab
Non-IAB Cookies‎

PERSONALISED ADS, AND AD MEASUREMENT

Personalised ads, and ad measurement

 * SELECT PERSONALISED ADS
   
   Switch Label
   
   Personalised ads can be shown to you based on a profile about you.

 * MEASURE AD PERFORMANCE
   
   Switch Label
   
   The performance and effectiveness of ads that you see or interact with can be
   measured.

 * CREATE A PERSONALISED ADS PROFILE
   
   Switch Label
   
   A profile can be built about you and your interests to show you personalised
   ads that are relevant to you.

 * SELECT BASIC ADS
   
   Switch Label
   
   Ads can be shown to you based on the content you’re viewing, the app you’re
   using, your approximate location, or your device type.

 * TARGETED ADVERTISING COOKIES
   
   Switch Label
   
   These Cookies are used to collect data about your browsing habits, use of the
   Services, your preferences, and your interaction with advertisements across
   platforms and devices for the purpose of delivering targeted advertising
   content, both on our Services and on third party sites. Third-party sites and
   services also use Targeting Cookies to deliver content, including
   advertisements relevant to your interests on the Services. If you reject
   these Cookies, you will see less relevant advertising.

List of IAB Vendors‎ | Detailed Purpose Descriptions Opens in a new Tab
Non-IAB Cookies‎

PERSONALISED CONTENT, CONTENT MEASUREMENT, AUDIENCE INSIGHTS, AND PRODUCT
DEVELOPMENT

Personalised content, content measurement, audience insights, and product
development

 * DEVELOP AND IMPROVE PRODUCTS
   
   Switch Label
   
   Your data can be used to improve existing systems and software, and to
   develop new products

 * SELECT PERSONALISED CONTENT
   
   Switch Label
   
   Personalised content can be shown to you based on a profile about you.

 * APPLY MARKET RESEARCH TO GENERATE AUDIENCE INSIGHTS
   
   Switch Label
   
   Market research can be used to learn more about the audiences who visit
   sites/apps and view ads.

 * CREATE A PERSONALISED CONTENT PROFILE
   
   Switch Label
   
   A profile can be built about you and your interests to show you personalised
   content that is relevant to you.

 * MEASURE CONTENT PERFORMANCE
   
   Switch Label
   
   The performance and effectiveness of content that you see or interact with
   can be measured.

 * CONTENT SELECTION COOKIES
   
   Switch Label
   
   This group is so Content Selection IAB group can have an id

List of IAB Vendors‎ | Detailed Purpose Descriptions Opens in a new Tab
Non-IAB Cookies‎

SOCIAL MEDIA COOKIES

Social Media Cookies

These Cookies are set by social media platforms on the Services to enable you to
share content with your friends and networks. Social media platforms have the
ability to track your online activity outside of the Services. This may impact
the content and messages you see on other websites you visit.

Non-IAB Cookies‎


BACK BUTTON PERFORMANCE COOKIES



Vendor Search Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label


 * 33ACROSS
   
   HOST DESCRIPTION
   
   VIEW COOKIES
   
   
    * Name
      cookie name

Confirm My Choices


We and our partners collect information from your device, such as device
identifiers, IP address, and your browser type to personalize and deliver
content, marketing and advertising—across devices and platforms; for analytics
and measurement, so we can improve our services and develop new ones; to match
and combine offline data with your online activity; and for social features. We
share this information with selected partners with your consent. By clicking “I
accept”, you consent to our use of these Cookies. Click Manage Choices to learn
more about these. We will also use other Cookies that are essential for our site
and Services, including for security and fraud prevention. To learn more about
some of our partners select Show Vendors. You can adjust your preferences at any
time via the “Manage Cookie Preferences” link in the footer of relevant
NBCUniversal websites or in-app settings. Visit our Cookie Notice and Privacy
Policy to learn more.


WE AND OUR PARTNERS PROCESS DATA FOR THE FOLLOWING PURPOSES:

Store and/or access information on a device. Personalised ads, and ad
measurement. Personalised content, content measurement, audience insights, and
product development. List of IAB Vendors

I Accept Manage Choices